Navigation Links
IIVS Announces Initiation by EPA of a Pilot Program to Evaluate Non-Animal Eye-Irritation Methods
Date:7/30/2009

GAITHERSBURG, Md., July 30 /PRNewswire-USNewswire/ -- The EPA has initiated a new program to evaluate the use of non-animal methods to replace the Draize test for eye irritation labeling for antimicrobial cleaning products. The is the first program of its kind and demonstrates the Agency's commitment to evaluate non-animal methods when valid alternatives are available.

IIVS was an integral part of the collaboration that led up to this initiative. Seven leading consumer product companies - The Procter & Gamble Company, Clorox, Colgate Palmolive, The Dial Corporation, Ecolab, JohnsonDiversey, Inc. and S.C. Johnson & Son, Inc. - provided data from in vitro as well as previously conducted animal studies on more than 300 representative cleaning products. IIVS, acting as a neutral party, collated the data, filled gaps with additional non-animal testing, and analyzed the predictive capacity of the alternative approach. Strong support from the animal protection community was also crucial to the success of the program.

"The acceptance of non-animal data by the EPA under this pilot program is a tremendous step forward in accelerating the application of scientifically sound alternative methods" said Dr Rodger Curren, President of IIVS. "IIVS was proud to contribute our experience and scientific expertise to both generate and analyze these complex data sets. We deeply appreciate the credence the EPA's leadership gives to in vitro methods and hope that this will lead to EPA guidelines that will more permanently cover this type of approach."

The goal of the EPA's pilot program is to evaluate the effectiveness of a non-animal testing method to replace the current Draize rabbit eye test. This approximately 18-month project encompasses the use of three in vitro assays: the Bovine Corneal Opacity and Permeability test (the use of eyes from cattle recently slaugh
'/>"/>

SOURCE Institute for In Vitro Sciences
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Cardium Announces New Orthobiologics Product Initiative Extending Gene Activated Matrix Technology to Deliver Bone Growth Factors
2. Micromet Announces Pricing of Public Offering of Common Stock
3. Cornerstone Therapeutics Announces Closing of Chiesi Transaction
4. Lotus Pharmaceuticals, Inc. Announces Patent Pending Gliclazide-Controlled Release Tablets
5. Repligen Announces Conference Call of First Quarter Fiscal Year 2010 Results
6. Oncolytics Biotech(R) Inc. Announces 2009 Second Quarter Results
7. Micromet Announces Public Offering of Common Stock
8. Amicus Therapeutics Announces Second Quarter 2009 Financial Results Release Date
9. Sanofi-aventis Announces Second Quarter 2009 Results
10. Human Genome Sciences Announces Pricing of Public Offering of Common Stock
11. Nuevolution Announces Worldwide Technology Cross-Licensing Agreement With GSK

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...sia/ -- Shanghai ChemPartner, as the,flagship subs...act Research,Organization (CRO), today announced i... 50 China, ranking 3rd on the list of the fastest-... a testament to ChemPartner,s outstanding,three-ye...e results of the 2009 Deloitte Technology Fast 50 ...
(Date:12/1/2009)...nounced a collaborative research agreement with Ro...ng EpiVax’s proprietary Tregitope technology...e responses to certain drugs. In the course of the...technology will be evaluated for its effect on the... (Vocus) December 2, 2009 -- To...
(Date:12/1/2009)...British Columbia, Dec. 1 ...f The Dow Chemical Company (NYSE: DOW ), and Agr...g of a research and commercial license option agre...h access to Agrisoma,s proprietary Engineered Trai...ajor food crops, and on a non-exclusive basis, in ...
(Date:12/1/2009)...g provider of products for biological sample colle...Services will offer Oragene•DNA sample collec...nd genotyping service. , ...k , a leading provider of products for biological ...armaceutical Services will offer Oragene•DN...
Breaking Biology Technology:Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 2Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 3EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 2EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 3Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 2Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 3Tepnel Pharmaceutical Services to Offer DNA Genotek's Sample Collection Kit in its Nucleic Acid Extraction and Genotyping Service 2Tepnel Pharmaceutical Services to Offer DNA Genotek's Sample Collection Kit in its Nucleic Acid Extraction and Genotyping Service 3
...ure,BioSciences, Inc. (Nasdaq: PBIO ) today annou...o discuss its second quarter 2008 financial result...ted may listen to the,teleconference either by tel...nce and web- cast information is provided below:, ... Eastern Time (ET), To attend this teleconference...
...stments,Inc. (Amex: MGT ), a technology holding c...ology ("HCIT") sector, today reported financial re...and provided an update on,strategic milestones., ..."Our results through,the first half of 2008 reflec...onCAD technology, as we work towards gaining regul...
...o, Inc.,(Nasdaq: BNVI ), a pharmaceutical company...and effective drugs in the areas of women,s health...SVP and CFO of Bionovo, will,be presenting at the ...ce,in Boston. The presentation is scheduled to beg...the InterContinental Boston Hotel., The presentat...
Other Biology Technology:Pressure BioSciences, Inc. to Discuss Second Quarter 2008 Financial Results and Provide Business Update 2MGT Capital Investments Reports Second Quarter 2008 Financial Results and Provides Update on Recent Developments 2MGT Capital Investments Reports Second Quarter 2008 Financial Results and Provides Update on Recent Developments 3MGT Capital Investments Reports Second Quarter 2008 Financial Results and Provides Update on Recent Developments 4MGT Capital Investments Reports Second Quarter 2008 Financial Results and Provides Update on Recent Developments 5Bionovo to Present at Canaccord Adams Global Growth Conference 2
(Date:12/1/2009)..., Particularly in Alzheimer,s disease, nerve cell... new therapeutic options may possibly be derived f...nism. These findings have been published in the cu...cience . Until only a few years ago, neurogenesis ...ered to be impossible in the adult brain. The text...
(Date:12/1/2009)..., In July the scientists, one from the United Sta...ar on Brutus, the leader of his wolf pack, on remo... Pole. Their goal to finally find out what these ...inter in one of the harshest areas of the world.,...2003," said David Mech, a renowned U.S. Geological...
(Date:12/1/2009)..., To Charles Darwin it was an ,abominable mystery...evolutionists to this day: when did flowering plan...life on earth? Today a study in Ecology Letters ...y flowering plants gaining a major competitive adv...uent boom and abundance. , The study, by Dr Tim ...
Breaking Biology News(10 mins):New source discovered for the generation of nerve cells in the brain 2North Pole wolf emails locations to researchers 2North Pole wolf emails locations to researchers 3How did flowering plants evolve to dominate Earth? 2Gen Probe Begins U S Clinical Study of APTIMA 28R 29 Trichomonas Vaginalis Assay on the TIGRIS 28R 29 System 54674 1Gen Probe Begins U S Clinical Study of APTIMA 28R 29 Trichomonas Vaginalis Assay on the TIGRIS 28R 29 System 54674 2Gen Probe Begins U S Clinical Study of APTIMA 28R 29 Trichomonas Vaginalis Assay on the TIGRIS 28R 29 System 54674 3Gen Probe Begins U S Clinical Study of APTIMA 28R 29 Trichomonas Vaginalis Assay on the TIGRIS 28R 29 System 54674 4Worries May Worsen Peripheral Arterial Disease 54672 1Worries May Worsen Peripheral Arterial Disease 54672 2Smoking Worsens Multiple Sclerosis 54670 1Smoking Worsens Multiple Sclerosis 54670 2Smoking Worsens Multiple Sclerosis 54670 3
..., The University of Chicago has received a $1.8 ...nch a new research program on the sudden and drama...small-scale structural rearrangements result in ra...reakup of splashing water droplets, the sudden mot...at occur in a dividing cell. , The University has...
..., , TEMPE, Ariz. An unusual new species of whirli...orbisonorum in honor of the late rock n roll legen...ate University entomologist Quentin Wheeler announ...ecies Jan. 25 during a Roy Orbison Tribute Concert...Us Center for Film, Media and Popular Culture and ...
..., The Chemical Heritage Foundation (CHF) announce...Pittcon Heritage Award. Jointly sponsored by the P...pplied Spectroscopy (Pittcon) and CHF, this award ...eurial careers have shaped the instrumentation com...rstanding of the modern instrumentation sciences, ...
Other Biology News:University of Chicago launches research program in catastrophic deformation 2University of Chicago launches research program in catastrophic deformation 3Whirligig beetle gets rock 'n' roll legendary name 2Leroy Hood to receive 2008 Pittcon Heritage Award 2Leroy Hood to receive 2008 Pittcon Heritage Award 3
...ocedure and streamlines the bisulfite method for D...hree step reaction that takes place between cytosi...d into uracil. The EZ DNA Methylation Kits innovat...everal precipitation steps and provides researcher...
Carbohydrate Analysis Standard, 6 vials from Bio-Rad
...s a dual capability system with the ability to pro...he specimen under test. While the XCAT series prov...mages, the micro focus source also allows the syst...images. The 50 mm x 50 mm digital detector provide...
General Side Effect Profile I (GEN SEP I) from Novascreen-a Caliper Life Sciences Company
Biology Products: